SCHEMBL97068

SCHEMBL97068

O=[C]c1cccc(I)c1

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28886 0.81 APP (0.35)
Hydrochloric Acid SCHEMBL9124177 0.78 CYP3A4 (0.33)
SCHEMBL11263406 0.76 PTPN5 (0.36)
SCHEMBL1070719 0.76 MAPT (0.35)
SCHEMBL80043 0.75
SCHEMBL5612881 0.75
SCHEMBL18245494 0.75
SCHEMBL29732358 0.75
SCHEMBL17983440 0.75
SCHEMBL1009061 0.73 ENPP2 (0.47)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 184 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20240033318-A1 PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION OHIO STATE INNOVATION FOUNDATION 2024-02-01 US claimed
US-11576946-B2 Peptidyl inhibitors of calcineurin-NFAT interaction OHIO STATE INNOVATION FOUNDATION (US) 2023-02-14 US claimed
CN-114716587-A Olefin polymerization solid catalyst component containing phenylacetate compounds, and preparation method and application thereof 中国科学院化学研究所 2022-07-08 CN claimed
US-20210169966-A1 PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION OHIO STATE INNOVATION FOUNDATION 2021-06-10 US claimed
EP-3749365-A2 PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION Ohio State Innovation Foundation (US) 2020-12-16 EP claimed
EP-3743061-A1 CANNABINOIDS AND DERIVATIVES FOR PROMOTING IMMUNOGENICITY OF TUMOR AND INFECTED CELLS Pascal Biosciences Inc. (CA) 2020-12-02 EP claimed
CN-110483503-A Imidazoles carbenes and its synthetic method and application with the long-range basic functionality of amide UNIV ZHEJIANG TECHNOLOGY 2019-11-22 CN claimed
WO-2019148194-A2 PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION OHIO STATE INNOVATION FOUNDATION (US) 2019-08-01 WO claimed
WO-2019144126-A1 CANNABINOIDS AND DERIVATIVES FOR PROMOTING IMMUNOGENICITY OF TUMOR AND INFECTED CELLS PASCAL BIOSCIENCES INC. (CA) 2019-07-25 WO claimed
EP-1937622-A1 COMPOUNDS FOR TREATMENT OF LIPASE-MEDIATED DISEASES Reliance Life Sciences Pvt., Ltd. (IN) 2008-07-02 EP claimed
US-20070054958-A1 Compounds for treatment of lipase-mediated diseases RELIANCE LIFE SCIENCES PVT. LTD. (IN) 2007-03-08 US claimed
WO-2007010546-A1 COMPOUNDS FOR TREATMENT OF LIPASE-MEDIATED DISEASES RELIANCE LIFE SCIENCES PVT LTD (IN) 2007-01-25 WO claimed
US-5919403-A POLYESTERS EASTMAN CHEMICAL COMPANY (US) 1999-07-06 US claimed
EP-0868465-A1 POLYMERIC FLUORESCENCE QUENCHING COMPOUNDS AND THEIR USE EASTMAN CHEMICAL COMPANY (US) 1998-10-07 EP claimed
WO-1997023540-A1 POLYMERIC FLUORESCENCE QUENCHING COMPOUNDS AND THEIR USE EASTMAN CHEMICAL COMPANY (US) 1997-07-03 WO claimed
US-4252719-A REMOVAL OF A TERTIARY HYDROGEN FROM A 5-A-STEROID BY CHLORINATING THE STEROID BEING FIRST ESTERIFIED BY AN IODOARYL-CONTAINING ESTERIFICATION AGENT RESEARCH CORPORATION (US) 1981-02-24 US claimed
US-4097678-A Δ9 (11) -5α-D-homo-20-keto steroids SCHERING AKTIENGESELLSCHAFT (DT) 1978-06-27 US claimed
US-4061661-A Δ9(11) -5α-20-KETO STEROIDS AND PROCESS FOR THEIR PRODUCTION SCHERING AKTIENGESELLSCHAFT (DT) 1977-12-06 US claimed
US-20240033318-A1 PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION OHIO STATE INNOVATION FOUNDATION 2024-02-01 US disclosed
US-4061661-A Δ9(11) -5α-20-KETO STEROIDS AND PROCESS FOR THEIR PRODUCTION SCHERING AKTIENGESELLSCHAFT (DT) 1977-12-06 US disclosed